These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14137376)

  • 21. POLIOMYELITIS IN UDAIPUR. A SMALL OUTBREAK IN 1963 AND THE USE OF SABIN VACCINE.
    SINGH S; MEHERHOMJI KM; GHARPURE PV
    J Indian Med Assoc; 1964 Aug; 43():153-9. PubMed ID: 14194411
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).
    Tagaya I; Nakao C; Hara M; Yamadera S
    Bull World Health Organ; 1973 May; 48(5):547-54. PubMed ID: 4359681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine.
    Takatsu T; Tagaya I; Hirayama M
    Bull World Health Organ; 1973; 49(2):129-37. PubMed ID: 4545320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Poliomyelitis due to poliovirus 3, with fatal outcome in an infant vaccinated with Sabin vaccine].
    Rocchi G; Giannini V; Provvidenza G; Andreoni G
    G Mal Infett Parassit; 1967 Jul; 19(7):463-5. PubMed ID: 4303743
    [No Abstract]   [Full Text] [Related]  

  • 25. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the Louisiana State Board of Health experience with the use of Salk vaccine and comments on the Sabin oral polio vaccine.
    HEDMEG A
    J La State Med Soc; 1963 Feb; 115():41-7. PubMed ID: 13963684
    [No Abstract]   [Full Text] [Related]  

  • 27. [VIROLOGICAL AND SEROLOGICAL STUDIES RELATED TO THE ORAL POLIOMYELITIS VACCINATION (SABIN TYPE I) IN SCHLESWIG-HOLSTEIN 1962].
    WITT G
    Zentralbl Bakteriol Orig; 1963 Jul; 189():345-7. PubMed ID: 14049327
    [No Abstract]   [Full Text] [Related]  

  • 28. MASS IMMUNISATION AGAINST POLIOMYELITIS IN CEYLON IN 1962 USING SABIN ORAL VACCINE.
    ARUMANAYAGAM P
    J Trop Med Hyg; 1965 May; 68():105-9. PubMed ID: 14287300
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of the Sabin vaccine in the interior of the state of Sao Paulo].
    da PRADO WS
    Arq Hig Saude Publica; 1962 Dec; 27():353-60. PubMed ID: 13985902
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary study of the second dose of Sabin vaccine and beginning of routine vaccination against poliomyelitis in the interior of the state of Sao Paulo (Brazil)].
    da PRADO WS
    Arq Hig Saude Publica; 1963 Mar; 28():81-8. PubMed ID: 13985901
    [No Abstract]   [Full Text] [Related]  

  • 31. [VIROLOGICAL STUDY DONE IN RELATION TO THE FIELD OF ORAL SABIN POLIO VACCINE].
    PEREZGALLARDO F; VALENCIANOCLAVEL L; GABRIELYGALAN J
    Rev Sanid Hig Publica (Madr); 1964; 38():502-10. PubMed ID: 14230442
    [No Abstract]   [Full Text] [Related]  

  • 32. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
    Minor PD
    J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mass administration of Sabin poliomyelitis vaccine (type II). Applications during a poliomyelitis epidemic (type I) in Kingston-upon-Hull (Great Britain) in the fall of 1961].
    HUISMAN J
    Tijdschr Soc Geneeskd; 1962 Jun; 40():35-8. PubMed ID: 14036442
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
    Liao G; Li R; Li C; Sun M; Li Y; Chu J; Jiang S; Li Q
    J Infect Dis; 2012 Jan; 205(2):237-43. PubMed ID: 22158682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DYNAMICS OF SEROLOGICAL SHIFTS IN CHILDREN VACCINATED WITH LIVE POLIOMYELITIS VACCINE FROM SABIN STRAINS].
    TARANOVA GP
    Vopr Virusol; 1963; 29():409-15. PubMed ID: 14071276
    [No Abstract]   [Full Text] [Related]  

  • 39. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of investigations made in the past 4 years on the immunization of several Soviet populations with live poliomyelitis vaccine (Sabin type) adminstered orally].
    CIUMAKOV MP; VOROSILOVA MK; DZAGUROV SG; DROZDOV SG; LASKEVICI VA; MIRONOVA LL
    Stud Cercet Inframicrobiol; 1962; 13():589-91. PubMed ID: 14021443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.